348 related articles for article (PubMed ID: 20731675)
21. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis.
Kankuri E; Hämäläinen M; Hukkanen M; Salmenperä P; Kivilaakso E; Vapaatalo H; Moilanen E
Scand J Gastroenterol; 2003 Feb; 38(2):186-92. PubMed ID: 12678336
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease.
Hollenbach E; Neumann M; Vieth M; Roessner A; Malfertheiner P; Naumann M
FASEB J; 2004 Oct; 18(13):1550-2. PubMed ID: 15289440
[TBL] [Abstract][Full Text] [Related]
23. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-1 stimulates proinflammatory cytokine expression in human periodontal ligament cells via mitogen-activated protein kinase pathway.
Liang L; Yu J; Zhou W; Liu N; E LL; Wang DS; Liu H
J Periodontol; 2014 Apr; 85(4):618-26. PubMed ID: 23701479
[TBL] [Abstract][Full Text] [Related]
25. Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.
Reddy KP; Markowitz JE; Ruchelli ED; Baldassano RN; Brown KA
Dig Dis Sci; 2007 Feb; 52(2):365-72. PubMed ID: 17219072
[TBL] [Abstract][Full Text] [Related]
26. No evidence for an involvement of the p38 and JNK mitogen-activated protein in inflammatory bowel diseases.
Malamut G; Cabane C; Dubuquoy L; Malapel M; Dérijard B; Gay J; Tamboli C; Colombel JF; Desreumaux P
Dig Dis Sci; 2006 Aug; 51(8):1443-53. PubMed ID: 16838116
[TBL] [Abstract][Full Text] [Related]
27. Role of p38 mitogen-activated protein kinase in Kupffer cell secretion of the proinflammatory cytokines after burn trauma.
Chen XL; Xia ZF; Wei D; Han S; Ben DF; Wang GQ
Burns; 2003 Sep; 29(6):533-9. PubMed ID: 12927976
[TBL] [Abstract][Full Text] [Related]
28. p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration.
Studer RK; Aboka AM; Gilbertson LG; Georgescu H; Sowa G; Vo N; Kang JD
Spine (Phila Pa 1976); 2007 Dec; 32(25):2827-33. PubMed ID: 18246004
[TBL] [Abstract][Full Text] [Related]
29. SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model.
Zhou WD; Yang HM; Wang Q; Su DY; Liu FA; Zhao M; Chen QH; Chen QX
Hum Reprod; 2010 Dec; 25(12):3110-6. PubMed ID: 20956267
[TBL] [Abstract][Full Text] [Related]
30. Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity.
Campbell RM; Anderson BD; Brooks NA; Brooks HB; Chan EM; De Dios A; Gilmour R; Graff JR; Jambrina E; Mader M; McCann D; Na S; Parsons SH; Pratt SE; Shih C; Stancato LF; Starling JJ; Tate C; Velasco JA; Wang Y; Ye XS
Mol Cancer Ther; 2014 Feb; 13(2):364-74. PubMed ID: 24356814
[TBL] [Abstract][Full Text] [Related]
31. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.
Kucharzik T; Lügering N; Weigelt H; Adolf M; Domschke W; Stoll R
Clin Exp Immunol; 1996 Jun; 104(3):483-90. PubMed ID: 9099934
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo?
Page TH; Brown A; Timms EM; Foxwell BM; Ray KP
Arthritis Rheum; 2010 Nov; 62(11):3221-31. PubMed ID: 20589681
[TBL] [Abstract][Full Text] [Related]
33. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.
Schreiber S; Heinig T; Thiele HG; Raedler A
Gastroenterology; 1995 May; 108(5):1434-44. PubMed ID: 7729636
[TBL] [Abstract][Full Text] [Related]
34. [Role of p38 mitogen-activated protein kinase pathway in pathogenesis of ulcerative colitis].
He FQ; Zou YP; Huang XL; Gao FJ; Peng L; Gan HT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 May; 44(3):393-6, 401. PubMed ID: 23898520
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages.
Smith SJ; Fenwick PS; Nicholson AG; Kirschenbaum F; Finney-Hayward TK; Higgins LS; Giembycz MA; Barnes PJ; Donnelly LE
Br J Pharmacol; 2006 Oct; 149(4):393-404. PubMed ID: 16953188
[TBL] [Abstract][Full Text] [Related]
36. Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes.
Rasheed Z; Akhtar N; Haqqi TM
Arthritis Res Ther; 2010; 12(5):R195. PubMed ID: 20955562
[TBL] [Abstract][Full Text] [Related]
37. Pancreatitis-associated ascitic fluid induces proinflammatory cytokine expression in THP-1 cells by inhibiting anti-inflammatory signaling.
Wang J; Xu P; Hou YQ; Xu K; Li QH; Huang L
Pancreas; 2013 Jul; 42(5):855-60. PubMed ID: 23774701
[TBL] [Abstract][Full Text] [Related]
38. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils.
Nick JA; Avdi NJ; Young SK; Lehman LA; McDonald PP; Frasch SC; Billstrom MA; Henson PM; Johnson GL; Worthen GS
J Clin Invest; 1999 Mar; 103(6):851-8. PubMed ID: 10079106
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogen-activated protein kinases.
Amrani Y; Ammit AJ; Panettieri RA
Mol Pharmacol; 2001 Oct; 60(4):646-55. PubMed ID: 11562425
[TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory effect and selectivity profile of AS1940477, a novel and potent p38 mitogen-activated protein kinase inhibitor.
Terajima M; Inoue T; Magari K; Yamazaki H; Higashi Y; Mizuhara H
Eur J Pharmacol; 2013 Jan; 698(1-3):455-62. PubMed ID: 23183108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
